Organization of the mouse RNA-specific adenosine deaminase Adar1 gene 5′-region and demonstration of STAT1-independent, STAT2-dependent transcriptional activation by interferon  by George, Cyril X. et al.
Virology 380 (2008) 338–343
Contents lists available at ScienceDirect
Virology
j ourna l homepage: www.e lsev ie r.com/ locate /yv i roOrganization of the mouse RNA-speciﬁc adenosine deaminase Adar1 gene 5′-region
and demonstration of STAT1-independent, STAT2-dependent transcriptional
activation by interferon
Cyril X. George a, Sonali Das a,1, Charles E. Samuel a,b,⁎
a Department of Molecular, Cellular and Developmental Biology, University of California, Santa Barbara, CA 93106, USA
b Biomolecular Sciences and Engineering Program, University of California, Santa Barbara, CA 93106, USAAbbreviations: ADAR, the RNA-speciﬁc adenosine d
feron; IFN, interferon; dsRNA, double-stranded RNA; bp
⁎ Corresponding author. Fax: +1 805 893 4724.
E-mail address: samuel@lifesci.lscf.ucsb.edu (C.E. Sam
1 Present address: Strand Life Sciences Pvt. Ltd., Bang
0042-6822/$ – see front matter © 2008 Elsevier Inc. Al
doi:10.1016/j.virol.2008.07.029a b s t r a c ta r t i c l e i n f oArticle history: The p150 form of the RNA-s
Received 3 June 2008
Returned to author for revision 27 June 2008
Accepted 25 July 2008
Available online 6 September 2008
Keywords:
Interferon
Signal Transducers and Activators of
Transcription (STAT)
Adenosine Deaminase Acting on RNA (ADAR)peciﬁc adenosine deaminase ADAR1 is interferon-inducible and catalyzes A-to-I
editing of viral and cellular RNAs. We have characterized mouse genomic clones containing the promoter
regions required for Adar1 gene transcription and analyzed interferon induction of the p150 protein using
mutant mouse cell lines. Transient transfection analyses using reporter constructs led to the identiﬁcation of
three promoters, one interferon-inducible (PA) and two constitutively active (PB and PC). The TATA-less PA
promoter, characterized by the presence of a consensus ISRE element and a PKR kinase KCS-like element,
directed interferon-inducible reporter expression in rodent and human cells. Interferon induction of p150
was impaired in mouse cells deﬁcient in IFNAR receptor, JAK1 kinase or STAT2 but not STAT1. Whereas Adar1
gene organization involving multiple promoters and alternative exon 1 structures was highly preserved,
sequences of the promoters and exon 1 structures were not well conserved between human and mouse.
© 2008 Elsevier Inc. All rights reserved.Introduction
Interferons (IFN) possess awide range of biologic activities (Borden
et al., 2007; Haller et al., 2006; Randall and Goodbourn, 2008; Samuel,
2001) that include modulation of the immune response, regulation of
cell growth and death, and the induction of a potent antiviral state, the
property by which interferons were discovered ∼50 years ago (Isaccs
and Lindenmann, 1957). Among the IFN-inducible genes is Adar1 that
encodes an adenosine deaminase acting on RNA (Bass et al., 1997;
Patterson and Samuel, 1995; Toth et al., 2006).
ADAR1 catalyzes the C-6 deamination of adenosine to yield inosine
in RNA substrates with double-stranded (ds) character (Samuel, 2001;
Valente and Nishikura, 2005; Toth et al., 2006). This A-to-I RNA
modifying activity of ADAR1 is implicated in two types of processes.
First, the deamination can be site-selective and occur at one or a few
sites, as illustrated by the editing of viral RNAs including the hepatitis
delta virus antigenome RNA (Jayan and Casey, 2002) and human
herpes virus 8 kaposin K12 transcript RNA (Gandy et al., 2007) and
cellular mRNA transcripts in the brain that encode receptors for L-




l rights reserved.al., 1993; Liu et al., 1999; Liu and Samuel, 1999). In these cases, the
positional selectivity of the RNA editing events generates protein
products with altered function because of the highly selective amino
acid substitutions introduced when GluR, 5-HT2cR, HHV8 and HDV
mRNAs are decoded by ribosomes as I is recognized as G instead of A
(Bass et al., 1997; Toth et al., 2006). Second, the dsRNA-speciﬁc
deamination can occur at multiple sites, as observed in the modiﬁca-
tion of viral RNA genomes during lytic and persistent infections
(Cattaneo, 1994; Bass et al., 1997). Such hypermutations of viral RNAs
have been characterized during replication and subsequent persistent
infection with certain single-stranded RNA viruses including measles
virus, where biased A-to-I (G) hypermutations were ﬁrst described
(Cattaneo et al., 1988), and more recently hepatitis C virus (Taylor et
al., 2007) and lymphocytic choriomeningitis (LCM) virus (Zahn et al.,
2007). In the case of measles virus, persistent infection may result in
subacute sclerosing panencephalitis (SSPE) and a fatal neuropathic
response (Oldstone, in press).
Although ADAR1 is IFN-inducible, a signiﬁcant basal level of
expression is found in cultured cells and animal tissues (Patterson et
al., 1995; Shtrichman et al., 2002; George et al., 2005). Immunoblot
and immunoﬂuorescent analyses with antisera raised against recom-
binant human ADAR1 demonstrated the expression of two differently
sized ADAR1 proteins, an IFN-inducible ∼150-kDa form found in both
the cytoplasm and nucleus, and a smaller ∼110-kDa N-terminally
truncated protein found predominantly if not exclusively in the
nucleus (Patterson and Samuel,1995). Both the inducible p150 and the
Fig. 1. Physical map of the 5′-region of the mouse Adar1 gene. The structure of the Adar1 gene is represented with regard to the organization of the exons and introns within the 5′-
region of the gene as established from λ-phage and BAC genomic clones. Exons are indicated by ﬁlled boxes, numbered 1–7; introns and the 5′- and 3′-ﬂanking regions are indicated
by the solid lines. The AUG for translation initiation of the IFN-inducible p150 ADAR1 protein is located in exon 1A; the AUG for initiation of the constitutively expressed p110 ADAR1
protein is located in exon 2. BAC-229 and BAC-232 genomic clones span the length of the Adar1 gene and continue into 5′-ﬂanking region. Restriction endonuclease cleavage sites:
HindIII (H), PstI (P), SacII (S), XbaI (X).
Table 1











Ms 1A 44 CCACAGgtaagcccgcgg IA 4.2 tgccttctacagGGGTGT 2
Hu 1A 201 CGGCAGgtaagccgggct IA 5.4 cttattctgcagGGGTAT 2
Ms 1B 106 GCGCGGgtaagaggacct IB 15.8 tgccttctacagGGGTGT 2
Hu 1B 107 GACCCGgtaagagcctct IB 14.5 cttattctgcagGGGTAT 2
Ms 1C 106 CAGAGGgtaaggcgttct IC 15.2 tgccttctacagGGGTGT 2
Hu 1C 107 AACCGTgtgagtactatt IC 3.1 cttattctgcagGGGTAT 2
Ms 2 1432 ACCTCGgtaagagactgc II 2.4 ctttccaccaagATTTAA 3
Hu 2 1586 ACCTCGgtaagagaccac II 2.5 ctttccgtcaagATTTAA 3
Ms 3 184 GAGAAGgtaggtgatctt III 1.0 tcttttctccagCCAGCA 4
Hu 3 184 GAGAAGgtaggtgtcctc III 0.4 cattttctctagACTGCA 4
Ms 4 149 CCCCAAgtatgtctatgt IV 0.6 gtttctgctaagGTTCCA 5
Hu 4 149 ACCCAAgtatgtcctacg IV 0.6 atctcctgtcagGTTCCA 5
Ms 5 139 GACCAGgtgggccgacgt V 0.1 atttctccttagTCTGGA 6
Hu 5 145 AACCAGgtagggcgtttt V 0.1 attctcctttagCCTGAA 6
Ms 6 184 ACCCAAgtgagtacctca VI 8.3 ttcatcccaaagGTTTGT 7
Hu 6 191 GCCCAAgtgagtgtccta VI 6.5 ctcatcccaaagGTTCGT 7
Ms 7A 226 AAGACAgttaagacatct VIIA 0.2 ctgtgtccgcagCTCCTC 8
Hu 7A 226 AAGACAgttaagacgtct VIIA 0.3 ttttccccacagCTCCCT 8
Ms 7B 148 ACAGAGgtaaccccagta VIIB 0.4 ctgtgtccgcagCTCCTC 8
Hu 7B 148 ACAGAGgtaaccccagtg VIIB 0.4 ttttccccacagCTCCCT 8
Ms, mouse; Hu, human. Upper case font, EXON sequence at junction; lower case font,
adjacent intron sequence at junction.
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that catalyze the A-to-I editing of synthetic and naturally occurring
substrates (Toth et al., 2006). Both the p150 and p110 forms of ADAR1
possess, in addition to the deaminase catalytic domain in the C-
terminal region, three copies of the dsRNA-binding motif in the
central region of the proteins (Kim et al., 1994; O'Connell et al., 1995;
Patterson and Samuel, 1995; Liu and Samuel, 1996). The IFN-inducible
form of ADAR1 also includes in the N-terminal region two copies of a
Z-DNA binding motif (Zα, Zβ) with homology to the poxvirus E3L
protein (Patterson and Samuel, 1995; Athanasiadis et al., 2005), the
physiologic function of which has not yet been clearly deﬁned. The
single human ADAR1 gene spans ∼40-kbp and includes 17 exons (Liu
et al., 1997) on chromosome 1q21.1–21.2 (Weier et al. 1995). The IFN-
inducible expression of p150 and constitutive expression of p110 are
achieved by a sophisticated and complex process that involves
alternative promoter utilization and alternative exon 1 splicing. One
promoter is IFN-inducible, and at least two are constitutively active
(George and Samuel, 1999a,b; Kawakubo et al., 2000). The promoters
drive the expression of human ADAR1 transcripts with alternative
exon 1 structures that are spliced to a common exon 2 junction;
translation initiation of the inducible p150 protein begins in
alternative exon 1A, whereas neither constitutive alternative exon
1B nor 1C contain an AUG start codon and translation of the p110
constitutive form of ADAR1 begins at an in-frame AUG within exon 2
(Valente and Nishikura, 2005; Toth et al., 2006). The expression of the
mouse Adar1 gene found on chromosome 3F2 (Weier et al., 2000)
likewise involves the utilization of multiple promoters and alternative
exon 1 splicing (George et al., 2005).
Because of the emerging role of ADAR1 as a determinant of the
outcome of virus–host interaction (Toth et al., 2006) and because of
the importance of the mouse model in studies of pathogenesis, it is
important to deﬁne the process of transcriptional activation of the
Adar1 gene. As a step toward this goal, we report herein the further
characterization of the 5′-region of the mouse Adar1 gene and the
identiﬁcation of an IFN-inducible STAT1-independent, STAT2-depen-
dent process of transcriptional activation of ADAR1 expression.
Results and discussion
Structural organization of the mouse Adar1 gene 5′-region through exon
7 is highly conserved with its human homolog
Overlapping λ-phage and bacterial artiﬁcial chromosome mouse
genomic clones were isolated that contain the Adar1 gene. They wereused to deﬁne the genomic organization of three alternative exon 1
structures (George et al., 2005) and to map the Adar1 gene to mouse
chromosome 3F2 (Weier et al., 2000). The mouse Adar1 genomic
clones were characterized by restriction enzyme analysis, by Southern
blot analysis, and by direct sequence analysis. A composite map is
shown in Fig. 1. The exon–intron boundaries of the exons 1–7 of the
mouse Adar1 gene are summarized in Table 1.
Comparison of the mouse Adar1 gene structure with that
previously determined for the human ADAR1 gene (Liu et al. 1997)
revealed that the exon–intron organization was highly conserved
between the mouse and human genes for the protein coding exons 2
through 7 (Table 1). The mouse Adar1 exon 1A (see Fig. 3A), like the
human ADAR1 exon 1A (George and Samuel, 1999b), includes the AUG
codon that begins the long open reading frame for the IFN-inducible
p150 ADAR1 protein. Neither mouse exon 1B nor 1C contained an
AUG; initiation of translation of the p110 constitutive form of mouse
ADAR1 would occur at AUG249 within exon 2, which conforms to
AUG296 within exon 2 of human ADAR1 (George and Samuel,
Fig. 2. Functional analysis of the mouse Adar1 gene 5′-ﬂanking region reporter gene
constructs by transient transfection. The ﬁreﬂy luciferase reporter plasmids (pLuc)
constructed by insertion of genomic DNA restriction fragments (see Fig. 1) from the 5′-
ﬂanking region of the Adar1 gene into the promoter-less pGL2 (pLuc-Basic) plasmid are
designated pLuc-A, pLuc-B and pLuc-C. Promoter activities were measured in the
following cells: (A) rat PC12; (B) mouse MEF; (C) human U cells. Open bars refer to cells
left untreated, and hatched bars refer to cells treated with IFN beginning at 24 h after
transfection. Transfections were repeated 3 to 5 times in independent experiments to
allow for calculation of a mean value and standard deviation. pLuc-Basic, the promoter-
less plasmid vector without inserted mouse genomic DNA. PKR, the pLuc-503(WT) PKR
promoter construct.
340 C.X. George et al. / Virology 380 (2008) 338–3431999a, 2005; Kumar and Carmichael, 1997; Liu et al., 1997). The
sizes of exons 2 through 7, and the adjacent introns II through VII,
are very similar if not identical for the mouse and human genes. Two
principal differences in size include exon 1A, which is somewhat
smaller in the mouse gene, and intron IC which is signiﬁcantly larger
than in the human gene. Two alternative exon 7 splice variants are
known in the human (Liu et al., 1997) and mouse (Shtrichman et al.,
2002) Adar1 genes. The presence of alternative exon 7b occurs with
exon 1A, and alternative exon 7a with exon 1B (George et al., 2005).
All splice sites of mouse Adar1 (Table 1), like human ADAR1 (Liu et al.,
1997), conformed to the GU–AG rule (Padgett et al., 1986) for introns I
to VII.
Functional identiﬁcation of the interferon-inducible and constitutive
mouse Adar1 promoter regions
Expression of exon 1A-containing ADAR1 RNA, but not exon 1B- or
1C-containing RNA, is increased by IFN treatment of mouse ﬁbroblasts
in culture (George et al., 2005). As an approach to the functional
isolation of the mouse Adar1 gene promoters, restriction fragments
from the 5′-ﬂanking region of the gene (Fig.1) were fused to the ﬁreﬂy
luciferase (Luc) reporter using the pGL2-basic plasmid vector. The
pLuc-A construct included the 320-bp HindIII-SacII fragment ﬂanking
exon 1A, pLuc-B contained the 350-bp Pst I fragment ﬂanking exon 1B,
and pLuc-C included a 330-bp Pst I fragment ﬂanking exon 1C. The
constructs were transfected into rat PC12 cells, mouse MEF cells, and
human U cells, and luciferase activity was measured in extracts
prepared from untreated or IFN-treated cells. The pLuc-A construct
exhibited strong and IFN-inducible promoter activity in all three cell
lines, whereas the activities of pLuc-B and pLuc-C were not increased
by IFN treatment in any of the cells tested (Fig. 2). The relative
activities of the three reporter constructs differed among the three cell
lines. Although the constitutive activity of pLuc-B was always greater
than that of the relatively weak pLuc-C, neither promoter construct
displayed increased activity following IFN treatment in PC12, MEF, or
U cells (Fig. 2). IFN treatment increased the activity of pLuc-A about 2-
to-3 fold, dependent upon the type of cell transfected, similar to that
seen for the human PKR promoter construct pLuc-503(WT) used as a
positive control. As a negative control, the promoter-less pGL2-basic
vector without inserted genomic DNA showed negligible activity even
following IFN treatment.
DNA sequence of the mouse Adar1 gene interferon-inducible promoter
region includes ISRE and KCS-like elements
The genomic DNA fragment ﬂanking exon 1A that possessed the
necessary functional elements to support basal and IFN-inducible PA
driven transcription in transfected cells was sequenced. The sequence
is shown in Fig. 3A. Among the DNA elements identiﬁed was a
consensus 13-bp IFNα/β-Stimulated Response Element (ISRE) found
in the promoters of most type I IFN-inducible genes that enhances
transcription in response to IFN treatment (Schindler et al., 2007;
Randall and Goodbourn, 2008). Immediately upstream of the ISREwas
a KCS-like element similar to the 15-bp KCS element found in both the
mouse and human PKR promoters that is essential for both basal and
IFN-inducible PKR promoter activity (Kuhen et al., 1998; Ward and
Samuel, 2002). Designated KCS for Kinase Conserved Sequence, it is
exactly conserved between the mouse and human PKR promoters in
sequence and position relative to the ISRE (Kuhen et al., 1998; Samuel,
2001). The KCS-like element sequence in themouse Adar1 PA promoter
was identical to the KCS-like sequence of the human IFN-inducible
ADAR1 promoter (Fig. 4). Eleven of the 15 bp of the KCS element
present in the PKR promoter, both mouse and human, were conserved
in the KCS-like element of the Adar1 promoter. However, the KCS-like
element is not essential for basal or IFN-inducible activity of the
human ADAR1 PI inducible promoter (Markle et al., 2003), andsubstitution of the human ADAR1 KCS-like element for the KCS
element of the human PKR promoter results in signiﬁcantly reduced
bsal and IFN-inducible PKR promoter activity (Ward et al., 2002).
Several candidate Sp1/Sp3 factor binding sites as well as PEA-3 and
MyoD sites were present in the mouse Adar1 PA promoter, however,
the inducible PA promoter sequence lacked TATA box and CATT box
initiation elements (Fig. 3A).
The DNA sequences were also determined for the Adar1 gene PB
(Fig. 3B) and PC (data not shown) promoter regions that possessed the
necessary elements to support constitutive transcription in transfected
Fig. 3. Nucleotide sequence of the 5′-ﬂanking region of the mouse Adar1 gene. The
sequences of the (A) PA and (B) PB promoter regions as well as the sequences of the
alternative exon 1A and exon 1B structures and adjacent introns are shown. Several
potential transcription factor binding sites as described in the text are shown, along
with landmark restriction endonuclease sites. The Interferon-Stimulated Response
Element (ISRE) and the Kinase Consensus Sequence (KCS)-like element are boxed.
341C.X. George et al. / Virology 380 (2008) 338–343rodent and human cell lines (Fig. 2). All sequences were reported in
the GenBank database. Among the binding sites found in the PB
region sequence were a consensus CAAT box, initiator positioning
sequence Inr and CRE-like motif (Fig. 3B), but no ISRE, GAS or KCS-
like elements were present in either the PB or the PC promoter
regions.Fig. 4. Comparison of the ISRE and KCS/KCS-like element sequences from the human
and mouse ADAR1 and PKR promoters. The sequence of the mouse (Mm) Adar1
interferon-inducible promoter region corresponding to the KCS-like and ISRE elements
is from Fig. 3; the sequence of the human (Hs) ADAR1 IFN-inducible promoter is from
George and Samuel (1999b). The mouse Pkr promoter sequence is from Tanaka and
Samuel (1994) and the human PKR promoter sequence is from Kuhen et al. (1998).Induction of mouse ADAR1 protein by interferon is JAK1- and
STAT2-dependent but STAT1-independent
The p150 ADAR1 protein encoded by exon 1A-containing RNA is
inducible by type I IFN (Patterson et al., 1995; George et al., 2005). The
canonical mode of transcriptional activation by type I IFN is by JAK-
STAT signaling (Borden et al., 2007; Schindler et al., 2007; Randall and
Goodbourn, 2008). Following binding of IFN-α/β to the IFNAR
receptor, the Tyk2 and JAK1 tyrosine kinases mediate activation of
the STAT1 and STAT2 transcription factors that together with IRF9
form the heterotrimeric ISGF3 complex that binds to the ISRE element
to enhance gene transcription. We used MEF cell lines with deﬁned
disruptions of genes encoding proteins involved in the canonical
signaling pathway to assess their requirement for p150 ADAR1 protein
induction by IFN. MEF cells were either treated with IFN or left
untreated, and then the level of p150 ADAR1 proteinwas measured by
immunoblot assay. The IFN-inducible expression of ADAR1 protein
was JAK1-dependent and IFN receptor-dependent, but unexpectedly
was independent of STAT1 (Fig. 5 A). Although not dependent on
STAT1, induction of ADAR1 p150 by IFN was dependent on STAT2 (Fig.
5 B). Controls included blotting with antibody against actin which
showed a similar protein loading; antibody against STAT1 which
veriﬁed the absence of STAT1 protein in the Stat1−/− MEF cells; and
antibody against STAT2 which veriﬁed the absence of STAT2 protein in
the Stat2−/− MEF cells (Fig. 5). Furthermore, STAT1α and β were
inducible in thewild-typeMEFs and Sp3−/−MEFs, but not in the Jak1−/−,
Stat2−/−, or Rc−/− MEFs. Finally, ADAR1 p150 induction also was
independent of the transcription factor Sp3 (Fig. 5 A), a component
of the KCS-binding protein complex (Das et al., 2006), as well as
independent of CEBPβ and CEPBδ (data not shown).Fig. 5. JAK1 and STAT2 but not STAT1 are necessary for induction of ADAR1 expression
by interferon alpha. Western immunoblot analysis of ADAR1 p150 protein expression in
WT and mutant MEF cell lines. Cells were either treated with IFN-αA/D (+) or left
untreated (−). Nonidet P-40 cell free extracts were prepared and ∼60 μg protein was
analyzed by Western immunoblotting as described under Materials and methods. (A)
Cell-free extracts prepared from WT and mutant MEF cells genetically deﬁcient in Sp3,
Stat1, Jak1 or the IFNAR receptor (Rc) as indicated. (B) Cell-free extracts prepared from
WT and mutant MEF cell lines genetically deﬁcient in Stat1 or Stat2.
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ADAR1 A-to-I editing enzyme by type I IFN is intriguing. Interestingly,
a second editing enzyme, APOBEC3G which catalyzes C-to-U deami-
nation of ssDNA is likewise induced by type I IFN in a STAT1-
independent, STAT2-dependent manner (Sarkis et al., 2006). The
mechanism underlying STAT1-independent signaling by IFN α/β to
activate ADAR1 expression remains unclear. Among the alternative
signaling pathways implicated in type I IFN-mediated responses are
those involving PI3K, p38, STAT3 or IRF3 (Platanias, 2005; Randall and
Goodbourn, 2008; Samuel, 2001; Stark, 2007). Furthermore, the IKK-
related kinase IKKε is necessary for the full transcriptional activation
of a subset of type I IFN-stimulated genes including Adar1, possibly
mediated through p38 kinase signaling (Tenoever et al., 2007).
Viruses have evolved a range of mechanisms by which IFN
signaling and the induction of an antiviral state are antagonized.
Among these mechanisms is an impairment of STAT1 function, for
example, by some paramyxoviruses including measles virus (Haller
et al., 2006; Randall and Goodbourn, 2008). A STAT1-independent
signaling response such as we ﬁnd for ADAR1 would provide the host
with an alternative mechanism for the induction of antiviral activities
by IFN. However, viruses are known to subvert the antiviral effects of
type I IFN through STAT2-dependent signaling, as has been demon-
strated for bothmeasles and LCMviruses that evade the immune system
through type I IFN-mediated STAT2-dependent but STAT1-independent
signaling (Hahm et al., 2005). Interestingly, bothmeasles virus and LCM
virus RNA genomes are implicated as targets of ADAR1 editing. A-to-G
mutations, consistent with the action of ADAR1, are observed in LCMV
genomic RNA; these mutations alter the functionality of viral glycopro-
teins at a high frequency (Zahn et al., 2007). A-to-Gmutations ofmeasles
virus genomic RNA also are seen with virus isolated from the brains of
SSPE patients (Cattaneo et al., 1988; Oldstone, in press).
Materials and methods
Cell maintenance and interferon treatment
Mouse embryo ﬁbroblast (MEF) cells, rat PC12 cells, and human
amnion U cells were maintained in Dulbecco's modiﬁed Eagle's
medium (DMEM) with 5% or 10% (v/v) fetal bovine serum (Hyclone),
respectively, and 1% sodium pyruvate (Cambrex Bio Science), 100 μg/
ml of penicillin and 100 U/ml streptomycin (GIBCO) as previously
described (Samuel and Knutson 1983, Das et al., 2006). Wild-type
(WT), Stat1−/−, Stat2−/−, Jak1−/−, Ifnar−/−, and Sp3−/− MEF cells were
generously provided by Dr. Robert Schreiber (Washington University,
St. Louis), Dr. Christian Schindler (Columbia University, New York) and
Dr. Guntrum Suske (Philipps-University, Marburg) (Bouwman et al.,
2000; Meraz et al., 1996, Park et al., 2000; Rodig et al., 1998). IFN
treatment was with 1000 U/ml of alpha IFN (PBL) for 24 h, using
recombinant IFN-αA/D (Samuel and Knutson, 1982).
Construction of reporter gene plasmids
pGL2-basic promoter-less plasmid (Promega) containing the ﬁreﬂy
luciferase (Luc) gene as the reporter was used for construction of the
Adar1 promoter plasmids. pLuc-503(WT) human PKRpromoter plasmid
was generously provided by Dr. P. Zhang of this laboratory. pRSV-βgal
was generously provided by Dr. J. Nevins (Duke University, Durham).
Transient transfection assays
Cells were transfected with the promoter plasmid constructs
containing the Luc reporter by the DEAE-dextran–chloroquine
phosphate transfection method (Luthman and Magnusson, 1983) as
described previously (Ward and Samuel, 2002). To normalize for
variations in transfection efﬁciency, cells were cotransfected with the
pRSV2-βgal construct as an internal reference. All DNA plasmids usedin transfections were puriﬁed by cesium chloride equilibrium
centrifugation; plasmid integrity was assessed by agarose gel
electrophoresis. IFN treatment was initiated 24 h after transfection.
Cells were harvested 48 h post-transfection, extracts prepared, and
protein concentrations determined by the modiﬁed Bradford method
(BioRad). Luciferase and β-galactosidase activities determined as
previously described (Das et al., 2006; Ward and Samuel, 2002).
Luciferase assays were quantiﬁed using an OPTOCOMP I luminometer.
Luciferase activity values were normalized by β-galactosidase activity
to control for variation in transfection efﬁciency. The data presented
are the average values derived from 3 to 5 independent experiments.
Promoter cloning
Mouse genomic clones λ52, BAC229 and BAC232 of Adar1 were
isolated as described (George et al., 2005) from two types of libraries, a
λ-phage genomic library in the vector EMBL-3 SP6/T7 (Clontech) and
the bacterial artiﬁcial chromosome (BAC) genomic library CitbCJ7
(California Institute of Technology). Restriction fragments of genomic
clones were subcloned into the pBluescript plasmid (Stratagene) for
detailed restriction mapping and DNA sequencing. Plasmid subclones
of the genomic DNAwere sequenced by the Sanger dideoxynucleotide
procedure using the Sequenase protocols from United States Bio-
chemical. Universal primer sites in the pBluescript plasmid were used
as well as custom Adar1 primers obtained commercially. Sequences
were analyzed using the University of Wisconsin Genetics Computer
Group programs on a Silicon Graphics IRIS 4D/340VGX computer.
Western immunoblot analysis
Cell-free extracts were prepared in the presence of 1 mM
phenylmethylsulfonyl ﬂuoride and 1% (v/v) protease inhibitor mixture
(Sigma) as described previously (Das et al., 2006). Proteins were
fractionated by sodium dodecyl sulfate-10% polyacrylamide gel
electrophoresis, transferred to nitrocellulose membranes, blocked,
and then probed with an appropriate dilution of primary antibody in
phosphate-buffered saline (PBS) containing 3% (w/v) skim milk and
0.05% Tween 20. Guinea pig polyclonal antibody prepared against a
mouse recombinant GST-ADAR1 [aa 574–968] fusion protein
expressed in E. coli was as previously described (George et al.,
2005). Rabbit polyclonal antibodies from Santa Cruz Biotechnology
were used to detect mouse STAT1α/β (M-22) andmouse STAT2 (L-22).
Mouse monoclonal antibody against β-actin was from Sigma (A-
5441). Western blot detectionwas done with horseradish peroxidase-
conjugated anti-guinea pig IgG, anti-rabbit IgG or anti-mouse IgG
secondary antibody using an ECL detection reagent kit (Amersham
Biosciences), according to the manufacturer's recommendations.
Immunoreactive bands were visualized using a VersaDoc (BioRad)
imaging system. Alternatively, secondary IRDye-conjugated antibo-
dies (Li-Cor) were used and immunoreactive bands were visualized
using an Odyssey infrared imaging system.
Nucleotide sequence accession numbers
The sequences reported in this paper have been deposited in the
GenBank database. The 5′-ﬂanking genomic sequence of the mouse
Adar1 gene including the interferon-inducible promoter PA region
and alternative exon 1A has been assigned the accession number
AY488121. The sequences of the constitutively active promoter PB and
PC regions and alternative exons 1B and 1C have been assigned the
accession numbers AY488122 and AY488123, respectively.
Materials
Unless otherwise speciﬁed, materials and reagents were as
described previously (George et al., 2005; Patterson and Samuel,1995).
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